The Long and Short
Broadridge Financial Solutions offers value relative to Moody’s
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
As the leading third-party provider of investor regulatory-required communications and proxy voting services, Broadridge Financial Solutions (BR, Baa1 (n)/BBB+ (n)/BBB+) has proven that even a pandemic will not hinder its organic growth or impede its stable cash flow generation. Despite leverage increasing to fund an acquisition with a new 10-year deal in the market, management will look to rapidly repay debt over the next two years, bringing leverage at or below its 2.5x leverage target. The credit provides value and is good name diversification for investor portfolios. The new 10-year deal priced at +105 bp, coming 30 bp (g-spread) behind Moody’s Corp (MCO – BBB+/BBB+) 2029 paper; prior to the start of the pandemic BR traded 25 bp back. Fair value is closer to 20 bp, with the potential to collapse further as the company reduces leverage closer to that of MCO’s.
BR has built up a sizeable client base as 900+ banks and brokers rely on its proxy management business, which has become the industry standard given its strong execution track record. Additionally, BR processes $7 trillion worth of fixed income and equity trades per day. As ubiquitous as Moody’s (MCO – BBB+/BBB+) and S&P (SPGI – A3/A-) is to credit ratings, BR garners the same recognition when it comes to proxies. BR’s business profile can be classified as strong, as it is underscored by a sizeable recurring revenue base.
What Pandemic?
BR’s results since the start of the pandemic have highlighted the minimal impact that the pandemic has had on both top line growth and cash flow generation. BR’s stable results are largely driven by its resilient recurring fee revenue base, which accounts for roughly 70% of total revenues and growing. For fiscal third quarter 2021, recurring fee revenues grew 8%, which was fueled by 7% organic growth. This remains within management’s historic mid-to-high single digit growth performance and demonstrates the strength of the company’s recurring revenue growth model. From a business perspective, the most recent quarterly results were largely driven by underlying growth trends due to record equity performance as well as increased growth across mutual funds and ETFs. While equity volume growth has been strong throughout BR’s fiscal 2021 thus far, management is forecasting growth of 25% in fiscal 4Q, which if achieved, would mark the strongest quarter for the year. In fact, we note that BR has witnessed five consecutive quarters of double-digit internal trade volume growth. Furthermore, boding well for future performance, BR continues to post revenue retention above 97%.
Exhibit 1: BR Key Volume Drivers (Fiscal 1Q20-Fiscal 3Q21)
Source: BR Investor Presentation; APS
Adjusted operating income was up 8% year-over-year, while the adjusted operating income margin contracted 60 bp (to 20.4%) in fiscal 3Q. Management noted that the margin decline reflected investments in the company’s technology platforms that they discussed last quarter. Free cash flow is somewhat seasonal with the majority generated during the fourth quarter. For the first nine months of the fiscal year, BR generated $136 million of free cash flow, which was up $54 million versus the prior year period and reflected increased platform and software spending.
Acquisition Increases Leverage – Management Focused on Rapid Debt Reduction
BR ended 3Q with debt/EBITDA of 1.5x and net leverage of 1.2x. However, the company’s leverage is expected to increase with the close of the Itiviti acquisition for $2.5 billion, which was announced in March 2021. The deal is expected to be financed with term and public debt with the company issuing $1 billion in 10-year bonds this week. Leverage is expected to approach the mid-3.0x area post close. While its leverage metric will be above the threshold for the current ratings, BR plans to use its strong free cash flow to delever rapidly as management has explicitly stated its commitment to its strong IG ratings. Management noted that they expect to hit their 2.5x leverage target within two years from the close. Given the company’s deleveraging plans, BR’s high BBB ratings were affirmed by both Moody’s and S&P with both agencies revising their outlooks to negative from stable. Fitch not only affirmed its BBB+ rating but left the outlook at stable. Moody’s and S&P were concerned with the company’s increased leverage target which moved from 2.0x to 2.5x. However, both agencies recognize that they company’s free cash flow provides for deleveraging to the 2.5x area within a two-year period. Should management hit its leverage target by fiscal year-end 2023, outlooks should be revised to stable. Furthermore, the acquisition helps to improve both scale and product capabilities while increasing its international presence.
Exhibit 2: BR fiscal year 2021 guidance
Source: BR Investor Presentation; Amherst Pierpont Securities
Full Year Guidance Increased
Given the better-than-expected results year-to-date, BR substantially increased its guidance for the year (Exhibit 3). While the new guidance reflects the impact from the Itiviti acquisition, the bulk of the revised guidance stems from the strong organic growth. Full year recurring revenue growth is now expected to be in the 8%-10% range, up from previous guidance of 3%-6% (management had expected results to come in at the high end of the range). Additionally, total revenue growth was raised to the 8%-10% range, which was up from initial guidance in the 1%-4% range. Management left its adjusted operating income margin at roughly 18%, which would translate to a 50 bp increase from fiscal year 2020. Management also increased its adjusted EPS guidance to the 11%-13% range (up from 6%-10%).
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2025 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
Important disclaimers for clients in the EU and UK
This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).
The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.
This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.
This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.
This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.
